Triple-valve surgery outcomes for active endocarditis versus other pathology: A statewide cohort study

JTCVS Open 2026 Open access

Read full text
Authors: Evan P. Rotar, Jared P. Beller, Matthew Weber, Steven Young, Jessica Zvara, Ramesh Singh, Mohammed A. Quader, Mark Joseph, Clifford Edwin Fonner, Adanna C. Akujuo, Leora T. Yarboro, John Kern
+1 more Michael A. Mazzeffi
DOI: 10.1016/j.xjon.2026.101701
Cited by: 0
References: 5

Abstract

Few previous studies have described triple-valve surgery outcomes in adults.1-5 A National Inpatient Sample study found that approximately 500 triple-valve surgery cases are performed yearly in the United States. Using a statewide database, we explored outcomes for patients who had triple-valve (aortic-mitral-tricuspid) surgery in Virginia. We hypothesized that patients having triple-valve surgery for active endocarditis would have greater postoperative morbidity and mortality than those having triple-valve surgery for other pathology.

Fields of Study & Subjects

Infective Endocarditis Diagnosis and Management Cardiac Valve Diseases and Treatments Congenital Heart Disease Studies

Publication details

Journal / source
JTCVS Open
Volume
30
Pages
101701–101701
Publication date
26 February 2026
Language
EN